DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,042 filers reported holding DANAHER CORPORATION in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $120,879,034 | -3.4% | 487,219 | -6.6% | 0.36% | +1.1% |
| Q2 2023 | $125,174,640 | -13.5% | 521,561 | -9.1% | 0.35% | -16.4% |
| Q1 2023 | $144,641,723 | -4.5% | 573,884 | +0.6% | 0.42% | -11.6% |
| Q4 2022 | $151,394,772 | +1.8% | 570,397 | -0.9% | 0.48% | +3.9% |
| Q3 2022 | $148,740,000 | +13.1% | 575,865 | +11.0% | 0.46% | +13.9% |
| Q2 2022 | $131,467,000 | -23.5% | 518,567 | -11.5% | 0.40% | -5.4% |
| Q1 2022 | $171,812,000 | -4.7% | 585,729 | +6.9% | 0.42% | -9.4% |
| Q4 2021 | $180,324,000 | +48.1% | 548,082 | +37.1% | 0.47% | +29.2% |
| Q3 2021 | $121,723,000 | +13.5% | 399,827 | +0.0% | 0.36% | +18.2% |
| Q2 2021 | $107,250,000 | +140.7% | 399,651 | +101.8% | 0.31% | +117.7% |
| Q1 2021 | $44,566,000 | -30.5% | 198,000 | -31.4% | 0.14% | -26.9% |
| Q4 2020 | $64,110,000 | +6.8% | 288,600 | +3.5% | 0.19% | -9.0% |
| Q3 2020 | $60,033,000 | +45.0% | 278,797 | +19.0% | 0.21% | +39.5% |
| Q2 2020 | $41,413,000 | +61.9% | 234,197 | +26.7% | 0.15% | +35.7% |
| Q1 2020 | $25,578,000 | -38.1% | 184,797 | -31.4% | 0.11% | -25.8% |
| Q4 2019 | $41,352,000 | +1.6% | 269,430 | -4.4% | 0.15% | -12.2% |
| Q3 2019 | $40,703,000 | +2.5% | 281,818 | +1.4% | 0.17% | +0.6% |
| Q2 2019 | $39,706,000 | -1.2% | 277,818 | -8.7% | 0.17% | -5.5% |
| Q1 2019 | $40,189,000 | +28.9% | 304,418 | +0.7% | 0.18% | +7.1% |
| Q4 2018 | $31,173,000 | -0.5% | 302,303 | +4.9% | 0.17% | +17.4% |
| Q3 2018 | $31,316,000 | -8.9% | 288,203 | -17.3% | 0.14% | -8.3% |
| Q2 2018 | $34,380,000 | -3.0% | 348,395 | -3.8% | 0.16% | -4.3% |
| Q1 2018 | $35,441,000 | +9.0% | 361,980 | +3.4% | 0.16% | +10.8% |
| Q4 2017 | $32,507,000 | +27.2% | 350,214 | +17.6% | 0.15% | +25.4% |
| Q3 2017 | $25,546,000 | -5.1% | 297,814 | -6.6% | 0.12% | -5.6% |
| Q2 2017 | $26,906,000 | -32.2% | 318,828 | -31.3% | 0.12% | -36.5% |
| Q1 2017 | $39,693,000 | +116.3% | 464,086 | +96.9% | 0.20% | +123.9% |
| Q4 2016 | $18,350,000 | -43.2% | 235,735 | -42.8% | 0.09% | -48.8% |
| Q3 2016 | $32,289,000 | -1.5% | 411,902 | +26.9% | 0.17% | -11.8% |
| Q2 2016 | $32,791,000 | +54.1% | 324,665 | +44.8% | 0.20% | +25.0% |
| Q1 2016 | $21,273,000 | -41.7% | 224,265 | -42.9% | 0.16% | -38.6% |
| Q4 2015 | $36,498,000 | +19.5% | 392,965 | +9.6% | 0.25% | +4.5% |
| Q3 2015 | $30,553,000 | +11.6% | 358,565 | +12.1% | 0.24% | +4.3% |
| Q2 2015 | $27,389,000 | +58.4% | 320,000 | +57.1% | 0.23% | +72.6% |
| Q1 2015 | $17,294,000 | +18.0% | 203,700 | +19.1% | 0.14% | +12.5% |
| Q4 2014 | $14,656,000 | +13.4% | 171,000 | +0.5% | 0.12% | +14.3% |
| Q3 2014 | $12,924,000 | -13.2% | 170,100 | -10.1% | 0.10% | -15.3% |
| Q2 2014 | $14,896,000 | -1.1% | 189,200 | -5.8% | 0.12% | -6.8% |
| Q1 2014 | $15,068,000 | -18.0% | 200,900 | -15.6% | 0.13% | -23.6% |
| Q4 2013 | $18,374,000 | +19.6% | 238,000 | +7.4% | 0.17% | +6.7% |
| Q3 2013 | $15,361,000 | +117.6% | 221,600 | +98.7% | 0.16% | +91.8% |
| Q2 2013 | $7,058,000 | – | 111,500 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |